The treatment of [IrCl(cod)]2 with (Z)-1-phenyl-2-(4′,4′-dimethyl-2′-oxazolin-2′-yl)-eth-1-en-1-ol (HL) in the presence of base yields the first Ir complex of this ligand class: Ir(κ2-N,O-L)(cod) (3). Complex 3 is reactive with MeI or HSnPh3 to yield the oxidative addition products 4 (trans-Ir(Me)I(κ2-N,O-L)(cod)) and 5 (cis-IrH(SnPh3)(κ2-N,O-L)(cod)), respectively. All three of these derivatives have been fully characterised including via single crystal X-ray diffraction data. Complex 3 is generally resistant to cod ligand substitution but shown to be reactive with CO (g) to give Ir(κ2-N,O-L)(CO)2 (6). In addition, 3 is demonstrated to be a dehydrogenation catalyst for the conversion of C8H16 into cyclooctene and H2 under acceptor-free conditions.
The electronic nature of the recently reported complex, bis((Z)-1-(benzo[d]oxazol-2-yl)-3.3.3-trifluoroprop-1-en-2-ate)palladium, is re-investigated by a combination of spectroscopy (NMR, IR, magnetic moment, etc.) and Density Functional Theory (DFT: B3LYP 6-31G*/LANL2DZ). In contrast to the recent report, the title complex displays all the properties of diamagnetism and hence retains the properties of a formally Pd(II) square planar complex with a bis-κ 2 -N,O-donor ligand set. A modified synthetic route is also presented which improves the yield of the compound.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.